← All trials
NCT04061798
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 2, 2020
- Primary completion
- Jan 1, 2024
- Completion date
- Nov 1, 2024
- First posted
- Aug 20, 2019
- Last posted
- Dec 6, 2022
- Enrollment
- 750
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Dijklander ZiekenhuisLead sponsor
- University of AmsterdamCollaborator
- Free University of AmsterdamCollaborator
- Dijklander ZiekenhuisReponsible party - principal investigator
- ZonMw: The Netherlands Organisation for Health Research and DevelopmentCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.